Companies / Immucell Corp /De/

Immucell Corp /De/

Nasdaq: ICCCCIK 811641PORTLAND, ME

Financials · FY2025

Revenue$27.64M
Net income$-1.04M
Total debt$18.16M
Cash$8.86M
Diluted EPS$-0.12
Shares outstanding9.0M

Ownership

9.0M shares outstanding · as of May 1, 2026
2.3%Insiders
Ownership
Insiders2.27%205,700
Institutions14.33%1,296,454
Public float83.40%7,544,645

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 5

View all →
Insider% of sharesShares
2.27%205,700
Brockmann Bobbi JoVP of Sales and Marketing · Director
Fiori Timothy CChief Financial Officer · Director
te Boekhorst Paul Francis OlivierCEOPresident and CEO · Director

Institutional holders 28

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 20, 2026Brigham Michael F
Director
ExerciseCommon Stock, par value $.01 per share$146.0K+25K
+12.21%
229,752
2.54% of shares
low
Mar 20, 2026Brigham Michael F
Director
OtherCommon Stock, par value $.01 per share$146.0K-24K
-10.47%
205,700
2.27% of shares
low
Apr 15, 2026Tomsche David Scott
Director
GrantNon Qualified Stock Options (Right to buy)+12K
11,933
0.13% of shares
low
Apr 16, 2025Tomsche David Scott
Director
GrantNon Qualified Stock Options (Right to buy)+10K
10,000
0.11% of shares
low
Jan 27, 2026te Boekhorst Paul Francis Olivier
CEO
GrantStock Options (right to buy)+110K
110,000
1.22% of shares
low
Jan 27, 2026te Boekhorst Paul Francis Olivier
CEO
GrantStock Options (right to buy)+110K
109,500
1.21% of shares
low
Jan 27, 2026Fiori Timothy C
Executive
GrantStock Options (right to buy)+120K
120,000
1.33% of shares
low
Jan 27, 2026Brockmann Bobbi Jo
Executive
GrantStock Options (right to buy)+100K
100,000
1.11% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
ICCCCommon StockEquity452525306BBG000BLQ5Q2